US equities
|
MU
$1,046.61
▼-1.74%
NVDA
$230.23
▲+0.81%
SNDK
$1,744.67
▲+0.27%
TSLA
$356.12
▲+0.37%
INTC
$119.90
▼-0.28%
GOOGL
$340.01
▼-1.18%
SPCX
$151.12
▲+0.18%
AMD
$611.78
▲+0.00%
MU
$1,046.61
▼-1.74%
NVDA
$230.23
▲+0.81%
SNDK
$1,744.67
▲+0.27%
TSLA
$356.12
▲+0.37%
INTC
$119.90
▼-0.28%
GOOGL
$340.01
▼-1.18%
SPCX
$151.12
▲+0.18%
AMD
$611.78
▲+0.00%
FinancialContent
Watchlist
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
My watchlist
My portfolio
Recent quotes
Silo Pharma, Inc. - Common Stock
(NQ:
SILO
)
1.495
-0.015 (-0.99%)
Delayed Quote
Updated: 12:18 PM EDT, Oct 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Silo Pharma, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
July 16, 2024
It's time to dive into the biggest pre-market stock movers as we check out all of the latest news worth reading about on Tuesday morning!
Via
InvestorPlace
Silo Pharma Secures Exclusive Global License for Alzheimer's Therapeutic
July 16, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Enters License Agreement with Columbia University for Lead Candidate Targeting PTSD, Stress-Induced Anxiety Disorders
July 08, 2024
Via
Investor Brand Network
Why Silo Pharma Stock Is Down Over 30%
↗
June 05, 2024
Silo Pharma shares are trading lower by 31% during Wednesday's session. The company announced it has entered into agreements to sell 917,432 shares of common stock.
Via
Benzinga
Silo Pharma Announces Exclusive, Global License for Lead Candidate SPC-15 Targeting PTSD and Stress-Induced Anxiety Disorders
July 08, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Collaborates with CRO Partner to Advance SPC-15 for PTSD
June 26, 2024
Via
Investor Brand Network
Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety
June 26, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
June 11, 2024
Via
Benzinga
PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Closes on $2M Registered Direct Offering, Provides Update on SP-26 Ketamine Implant Therapeutic
June 07, 2024
Via
Investor Brand Network
Silo Pharma Announces Successful Production of its SP-26 Ketamine Implant for Fibromyalgia
June 07, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
Silo Pharma Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
June 06, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
Crude Oil Rises 1%; Dollar Tree Shares Fall After Q1 Results
↗
June 05, 2024
Via
Benzinga
Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
June 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
June 05, 2024
Via
Benzinga
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Enters Registered Direct Offering Estimated to Reach $2M
June 05, 2024
Via
Investor Brand Network
Gold Gains 1%; ISM Services PMI Surges In May
↗
June 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
June 05, 2024
Via
Benzinga
Silo Pharma Announces $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
June 05, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Pre-IND Submission for Proprietary Treatment for PTSD, Anxiety
June 04, 2024
Via
Investor Brand Network
Silo Pharma Submits Pre-Investigational New Drug Application to FDA for SPC-15 as a Treatment for PTSD and Anxiety
June 04, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
Silo Pharma’s (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors
June 04, 2024
Via
AB Newswire
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
May 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
May 23, 2024
Via
Benzinga
PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Shares ‘Significant Development’ in Depression Study Showing Potential to Extend Remission Period, Prevent Relapse
May 21, 2024
Via
Investor Brand Network
Silo Pharma Announces Positive Results from Study for Depression Treatment, Remission, and Relapse Prevention
May 21, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) Announces Participation in FDA Event Exploring Emerging Therapeutic Interest in Ketamine
May 14, 2024
Via
Investor Brand Network
Silo Pharma to Participate in FDA Meeting Exploring Emerging Therapeutic Interest in Ketamine
May 14, 2024
Silo’s SP-26 currently in development utilizes ketamine as primary therapeutic agent
From
Silo Pharma, Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Shares Positive Results for PTSD Treatment
April 23, 2024
Via
Investor Brand Network
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
April 23, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
↗
April 17, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
